Thomas S Harrison Selected Research

Fluconazole (Zonal)

1/2022	Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
12/2020	Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.
10/2020	Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.
1/2020	Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis.
12/2019	Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
1/2019	Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.
1/2019	Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
10/2018	Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report.
10/2018	High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.
1/2018	Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas S Harrison Research Topics

Disease

58	Cryptococcal Meningitis 06/2022 - 05/2004
13	Infections 10/2020 - 02/2005
8	Cryptococcosis 01/2022 - 05/2004
6	Meningoencephalitis 12/2019 - 02/2010
5	Meningitis 12/2020 - 03/2007
5	Tuberculosis (Tuberculoses) 07/2020 - 02/2010
4	Body Weight (Weight, Body) 01/2022 - 03/2007
3	Mycoses (Diseases, Fungus) 06/2022 - 01/2003
3	HIV Infections (HIV Infection) 10/2020 - 05/2015
3	Aneuploidy (Aneuploid) 12/2019 - 01/2018
3	Immune Reconstitution Inflammatory Syndrome 10/2018 - 06/2010
3	Anemia 01/2018 - 01/2012
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2017 - 08/2011
3	Hypokalemia 01/2017 - 01/2012
2	Pulmonary Tuberculosis 01/2019 - 10/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2018 - 01/2017
2	Headache (Headaches) 10/2018 - 10/2018
2	Ototoxicity 01/2017 - 08/2011
2	Extensively Drug-Resistant Tuberculosis 01/2017 - 05/2015
2	Neutropenia 12/2015 - 02/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	COVID-19 01/2021
1	Chromosome Duplication 12/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2018
1	Neoplasms (Cancer) 12/2018
1	Fever (Fevers) 10/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2018
1	Hearing Loss (Hearing Impairment) 01/2017
1	Vitamin D Deficiency 08/2014
1	Inflammation (Inflammations) 01/2014
1	Central Nervous System Diseases (CNS Diseases) 01/2013
1	Invasive Fungal Infections 08/2012
1	Aspergillosis 11/2009
1	Mannose-Binding Protein Deficiency 11/2009
1	Vision Disorders (Hemeralopia) 11/2005
1	Bacterial Infections (Bacterial Infection) 02/2005

Drug/Important Bio-Agent (IBA)

27	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 05/2004
18	Flucytosine (Ancobon)FDA Link 01/2022 - 05/2004
17	AntigensIBA 01/2022 - 08/2005
15	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2020 - 05/2004
7	liposomal amphotericin B FDA Link 01/2022 - 07/2013
7	Pharmaceutical PreparationsIBA 01/2019 - 05/2004
4	deoxycholate drug combination amphotericin BIBA 01/2022 - 07/2013
3	Antifungal AgentsIBA 06/2022 - 06/2013
3	Capsules (Microcapsules)IBA 01/2018 - 09/2006
3	InterferonsIBA 01/2014 - 06/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 09/2006
2	chinese inkIBA 01/2022 - 10/2018
2	rifapentine (Priftin)FDA Link 01/2019 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2017
2	ElectrolytesIBA 01/2017 - 12/2015
2	Capreomycin (Capastat)FDA Link 01/2017 - 08/2011
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 08/2011
2	CreatinineIBA 12/2015 - 01/2012
2	CytokinesIBA 04/2015 - 02/2005
2	EnzymesIBA 11/2009 - 01/2003
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Macrophage Colony-Stimulating FactorIBA 11/2020
1	lipoarabinomannan (LAM)IBA 07/2020
1	RifamycinsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2018
1	CarbonIBA 12/2018
1	dimemorfan (AT 17)IBA 10/2018
1	FluoroquinolonesIBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	ChemokinesIBA 04/2015
1	Genetic Markers (Genetic Marker)IBA 01/2015
1	Moxifloxacin (Avelox)FDA Link 10/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2014
1	Pyrazinamide FDA LinkGeneric 10/2014
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2014
1	Ethambutol (Myambutol)FDA LinkGeneric 10/2014
1	hydroxide ionIBA 08/2014
1	25-hydroxyvitamin DIBA 08/2014
1	LaccaseIBA 05/2014
1	Interleukin-7 (Interleukin 7)IBA 01/2014
1	InterleukinsIBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Voriconazole (Vfend)FDA LinkGeneric 01/2012
1	PotassiumIBA 01/2012
1	Saline SolutionIBA 01/2012
1	LipidsIBA 02/2010
1	Pattern Recognition ReceptorsIBA 11/2009
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2009
1	Complement System Proteins (Complement)IBA 11/2009
1	ImmunosorbentsIBA 11/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	Interleukin-10 (Interleukin 10)IBA 03/2007

Therapy/Procedure

43	Therapeutics 06/2022 - 05/2004
5	Art Therapy 10/2021 - 01/2013
3	Immunotherapy 11/2020 - 06/2012
2	Injections 01/2017 - 08/2011
1	Aftercare (After-Treatment) 01/2017
1	Duration of Therapy 01/2017
1	Immunomodulation 04/2015